1Harboe M, Oettinger T, Wiker HG, et al. Evidence for occurrence of the ESAT 6 protein in Mycobacterium tuberculosis and virulent Mycobaelerium bovis and for its absence in Mycobacterium boris BCG[J]. Infect Immun, 1996,64(1 ): 16-22.
2Skjot RL, Oettinger T, Rosenkrands I, et al. Comparative evaluation of low molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T cell antigens[J]. Infect Immun,2000,68(1) :214-220.
3Mustafa AS, Amoudy HA, Wiker HG, et al. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis[J]. Scand J Immunol, 1998,48 (5) : 535-543.
4Wu-Hsieh BA,Chen CK,Chang JH,et al. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis [J]. Clin Infect Dis,2001,33(8) :1336-1340.
5Silva VM, Kanaujia G, Gennaro ML, et al. Factors associated with humoral response to ESAT 6,38 kDa and 14 kDa in patients with a spectrum of tuberculosis[J]. Int J Tuberc Lung Dis,2003,7(5):478-484.
6Ravn P,Munk ME, Andersen AB,et al. Prospective evaluation of a whole-blood test using Mycobaeterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis[J]. Clin Diagn Lab Immunol, 2005,12(4) :491-496.
7Ravn P, Demissie A, Eguale T, et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tubereulosis[J]. J Infect Dis, 1999,179(3) :637-645.
8Arend SM, Andersen P, van-Meijgaarden KE, et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6 kDa protein and culture filtrate protein 10[J]. J Infect Dis,2000,181(5):1850- 1854.
9Lein AD,von-Reyn CF,Ravn P,et al. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis[J]. Clin Diagn Lab Immunol, 1999,6(4): 606-609.
10Arend SM, Ottenhoff TH, Andersen P, et al. Uncommon presentations of tuberculosis:the potential value of a novel diagnostic assay based on the Mycobacterium tuberculosis specific antigens ESAT 6 and CFP-10[J]. Int J Tuberc Lung Dis,2001,5(7) :680-686.
4WHO. Global tuberculosis control 2011 report E R. Geneva: Switzerland, 2011.
5Druszczynska M,Kowalewicz-Kulbat M,Fol M,et al. Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies[J 7. Pol J Microbiol, 2012,61 ( 1 ) : 3-10.
6Triverio PA,Bridevaux PO, Roux-Lombard P, et al. Interferon- gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients [J]. Nephrol Dial Transplant, 2009,24 (6) : 1952-1956.
7Yang FF, Tu ZQ, Fang YM, et al. Monitoring of peptide- specific and interferon-7-productive T cells in patients with active and convalescent tuberculosis using ELISPOT['J]. Clin Vaccine Immunol,2012,19(3) :401-410.
8Chiappini E, Bonsignori F, Accetta G, et al. Interferon-7 release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review [- J ]. Int J Immunopathol Pharmaco|,2012,25(2) :335-343.
9Simsek H, Alpar S, Ucar N, et al. Comparison of tuberculin skin testing and T-SPOT. TB for diagnosis of latent and active tuberculosis[J]. Jpn J Infect Dis,2010,63(2) :99-102.
